diarrhea after stopping tirzepatide vs. Semaglutide for Weight Loss Stopping Tirzepatide Leads to Rebound
Description
Healio recently wrote about interesting new research shared by Tina Yi-Jin Hsieh, MD MPH, clinical researcher at Harvard Medical School showing that GLP-1 receptor agonists can reduce the risk of uterine fibroids in women with type 2 diabetes
While promising effects on blood pressure and arterial stiffness were seen in at-risk groups, long-term and dose-specific studies are still needed to confirm clinical benefits.
Your body produces GLP-1 naturally, but modern eating patterns often suppress this appetite-regulating hormone
Gain insights for a smoother medication experience.
